USPTO serial 98101090
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Neelam Singh
Neelam Singh SINGH LAW PRACTICE, LLC403 6TH AVENUESUITE 12BROOKLYN, NY 11215| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Health care; Health care services for treating gastrointestinal conditions, hemorrhoids, chronic diseases, neurological disorders, reproductive-related issues, cancer, inflammation, immune diseases, autoimmune diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, chronic pain and nutritional, vitamin and mineral deficiencies; Health care services, namely, hemorrhoid treatment, infusion therapy, urgent care, primary health care and women's health care; Health assessment services; Health center services; Individual medical counseling services provided to patients; Integrated outpatient health care services; Intravenous (IV) hydration therapy services; Medical analysis services relating to the treatment of persons; Medical diagnosis and treatment of gastrointestinal conditions, hemorrhoids, chronic diseases, neurological disorders, reproductive-related issues, cancer, inflammation, immune diseases, autoimmune disorders, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, chronic pain and nutritional, vitamin or mineral deficiencies; Medical evaluation of gastrointestinal conditions, hemorrhoids, chronic diseases, neurological disorders, reproductive-related issues, cancer, inflammation, immune diseases, autoimmune diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, chronic pain and nutritional, vitamin and mineral deficiencies; Medical examination services; Medical services in the field of gastrointestinal health, perianal health, women's health and infusion therapy; Medical services, namely, treating gastrointestinal conditions, hemorrhoids, chronic diseases, neurological disorders, reproductive-related issues, cancer, inflammation, immune diseases, autoimmune disorders, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, chronic pain and nutritional and vitamin or mineral deficiencies; Medical testing services relating to the diagnosis and treatment of disease; Medical analysis for the diagnosis and treatment of persons; Medical screening; Medical services; Outpatient and inpatient care services; Physical fitness assessment services for medical purposes; Primary care medical services; Providing health information; Providing medical information via a website; Providing personalized healthcare and medical information in the nature of gastrointestinal health, perianal health, women's health and infusion therapy; Telemedicine services; Urgent medical care centers; Conducting medical physical evaluations; Health clinic services; Medical clinic services; Medical clinics; Providing health care information by telephone; Providing health care information by telephone and the internet; Providing medical advice in the field of gastrointestinal health, perianal health, women's health and infusion therapy; Providing medical information in the field of gastrointestinal health, perianal health, women's health and infusion therapy; Provision of medical information; Provision of medical services by health care professionals via the internet or telecommunication networks; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; Walk-in medical clinic services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 16, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 1, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 9, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 9, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 9, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 9, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 25, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 30, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 30, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 28, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 28, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 28, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 27, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 28, 2023 | NWAP | NEW APPLICATION ENTERED | — |